Review
doi: 10.1111/j.1440-0960.1993.tb00834.x.
Ocular complications of PUVA therapy
Affiliations
- PMID: 8240180
- DOI: 10.1111/j.1440-0960.1993.tb00834.x
Item in Clipboard
Review
Ocular complications of PUVA therapy
Australas J Dermatol.
1993.
Abstract
PUVA, the combination of psoralen and long wave ultraviolet radiation is widely used in the management of psoriasis, vitiligo and several other dermatological disorders. The potential for long term treatment to cause ocular damage remains to be determined and despite the large numbers of patients who have received PUVA treatment, development of cataract is exceedingly rare. This paper discusses cataract formation, reviews the literature concerning the ocular complications of PUVA therapy and proposes guidelines for ocular protection during photochemotherapy.
Similar articles
-
Psoralens and ocular effects in humans.Natl Cancer Inst Monogr. 1984 Dec;66:235-9. Natl Cancer Inst Monogr. 1984. PMID: 6531036
-
Lenticular psoralen photoproducts and cataracts of a PUVA-treated psoriatic patient.Arch Dermatol. 1985 Oct;121(10):1307-8. Arch Dermatol. 1985. PMID: 4037825
-
Lens opacities appearing during therapy with methoxsalen and long-wavelength ultraviolet radiation.Can J Ophthalmol. 1984 Jun;19(4):173-5. Can J Ophthalmol. 1984. PMID: 6744101
-
Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?Drug Saf. 1999 Apr;20(4):289-97. doi: 10.2165/00002018-199920040-00001. Drug Saf. 1999. PMID: 10230579 Review.
-
Side-effects of psoralen photochemotherapy (PUVA).Br J Dermatol. 1990 Jun;122 Suppl 36:117-25. doi: 10.1111/j.1365-2133.1990.tb02889.x. Br J Dermatol. 1990. PMID: 2196078 Review.
Cited by
-
Identifying and Treating Ocular Manifestations in Psoriasis.Am J Clin Dermatol. 2022 Jan;23(1):51-60. doi: 10.1007/s40257-021-00648-x. Epub 2021 Nov 3. Am J Clin Dermatol. 2022. PMID: 34731450 Review.
-
The effect of octreotide against oxidative damage in photosensitized conjunctiva and cornea of rabbits.Doc Ophthalmol. 2005 Mar-May;110(2-3):193-201. doi: 10.1007/s10633-005-4902-2. Doc Ophthalmol. 2005. PMID: 16328927
-
Comparative tolerability of systemic treatments for plaque-type psoriasis.Drug Saf. 2002;25(13):913-27. doi: 10.2165/00002018-200225130-00003. Drug Saf. 2002. PMID: 12381213 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
